2001 ROSS AVENUE, SUITE 3400, DALLAS, TX
Other Events
Unregistered Sales of Equity Securities
Shareholder votes
Material disclosure
Q2
Q1
FY 2025
Q3
FY 2024
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Amended Schedule 13D - Ownership Report
Amended Form D Notice of Exempt Offering of Securities